Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-15

Clinical Trial Update: Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating empagliflozin effects on macrovascular and microvascular circulation and endothelial function in adults with type 2 diabetes; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Empagliflozin (empagliflozin)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Diabetes Mellitus Type 2 | Phase 3 | Status: COMPLETED